Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access ...

A recent study reveals that weight-loss medications such as Ozempic may reduce the risk of obesity-related cancers, including ...

Primary care providers can use a new clinical advisory guideline to nutritionally support patients who are using GLP-1 ...

A growing number of obese adults and children have been prescribed Ozempic or similar medications to lose weight ...

A doctor has spoken about their own '100-year-old rule' they have when it comes to things like taking Ozempic.

Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...

Sure, I wee like Austin Powers and the number twos are like tennis balls – get comfortable with that idea. But I’m the best ...

For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased risk for psychiatric adverse events or worsening ...

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes ...

They have been called miraculous and the fastest way to lose weight, but how exactly do these weight loss-drugs work – and ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...